State Pauses J&J Vaccine, Won’t Slow Down Successful Roll Out
Concord, NH – The State of New Hampshire has announced a pause on the use of the Johnson & Johnson (J&J) COVID-19 vaccine, consistent with the recommendation of the federal government.
This morning, the U.S. Centers for Disease Control and Prevention and the Food and Drug Administration recommended a pause on the use of the single-dose J&J COVID-19 vaccine after reports that six individuals in the U.S. developed a rare disorder involving blood clots within about two weeks after vaccination.
The State of New Hampshire is working with all partners to ensure they are adjusting their operations to accommodate this pause.
“This news will not slow down New Hampshire,” said Governor Chris Sununu. “While the federal government has directed a brief pause in the J&J vaccine, the state is already working with our partners to ensure that they have an alternative supply of Pfizer or Moderna to help continue their efforts today.”
Currently, no state managed fixed sites are scheduled to hold Johnson and Johnson clinics.
Some Regional Public Health Networks were scheduled to provide Johnson & Johnson at clinics and to homebound populations today. The state is working with them to provide them with an alternative supply of Pfizer or Moderna vaccine so that their efforts do not slow down as a result of this pause.
Through the Federal Pharmacy Program, Walmart locations had planned to administer Johnson & Johnson today. All Walmart locations will have an alternative vaccine by 1pm today – if someone has an appointment after 1pm, they are encouraged to attend. If they have an appointment at Walmart before 1pm, they are welcome to visit any of the state-managed sites and their appointment will be honored.
This announcement is specific to the J&J COVID-19 vaccine and not related to the Moderna and Pfizer vaccines. We encourage people to continue with their scheduled appointments.
COVID-19 vaccine safety is a top priority and all reports of health problems following COVID-19 vaccination area taken very seriously. The CDC has indicated that those who have received the Johnson & Johnson vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their healthcare provider.
COVID-19 Summary Report
(data updated as of April 12, 2021- 9:00 AM)
- Number of Persons with COVID-191 89,229
- Recovered 84,588 (95%)
- Deaths Attributed to COVID-19 1,257 (1%)
- Total Current COVID-19 Cases 3,384
- Current Hospitalizations 118
- Total Persons Tested at Selected Laboratories, Polymerase Chain Reaction (PCR)2 675,941
- Total Persons Tested at Selected Laboratories, Antibody Laboratory Tests2 39,026
- Persons with Specimens Submitted to NH PHL 71,177
- Persons with Test Pending at NH PHL3 132
1 Includes specimens positive at any laboratory and those confirmed by CDC confirmatory testing.
2 Includes specimens tested at the NH Public Health Laboratories (PHL), LabCorp, Quest, Dartmouth-Hitchcock Medical Center, Mako, certain hospital laboratories, the University of New Hampshire and their contracted laboratory, and those sent to CDC prior to NH PHL testing capacity.
3 Includes specimens received and awaiting testing at NH PHL. Does not include tests pending at commercial laboratories.
NH DHHS COVID-19 Update – April 12, 2021
Concord, NH – The New Hampshire Department of Health and Human Services (DHHS) has issued the following update on the new coronavirus, COVID-19.
On Monday, April 12, 2021, DHHS announced 380 new positive test results for COVID-19, for a current PCR test positivity rate of 9.8%. Today’s results include 210 people who tested positive by PCR test and 170 who tested positive by antigen test. There are now 3,384 current COVID-19 cases diagnosed in New Hampshire. Of the results reported today:
4/11: 380 new cases
Several cases are still under investigation. Additional information from ongoing investigations will be incorporated into future COVID-19 updates. Of those with complete information, there are sixty-two individuals under the age of 18 and the rest are adults with 53% being female and 47% being male.
The new cases reside in Rockingham (91), Hillsborough County other than Manchester and Nashua (56), Strafford (43), Belknap (31), Merrimack (30), Grafton (18), Cheshire (7), Sullivan (7), Carroll (6), and Coos (2) counties, and in the cities of Manchester (31) and Nashua (30).
The county of residence is being determined for twenty-eight new cases.
Community-based transmission continues to occur in the State and has been identified in all counties.
Of those with complete risk information, most of the cases have either had close contact with a person with a confirmed COVID-19 diagnosis or have recently traveled.
There are currently 118 individuals hospitalized with COVID-19. In New Hampshire since the start of the pandemic, there have been a total of 89,229 cases of COVID-19 diagnosed.